نتایج جستجو برای: 177lu psma

تعداد نتایج: 2383  

Journal: :The Prostate 2017
Ismaheel O Lawal Alfred O Ankrah Neo P Mokgoro Mariza Vorster Alex Maes Mike M Sathekge

BACKGROUND Emerging data from published studies are demonstrating the superiority of Ga-68 PSMA PET/CT imaging in prostate cancer. However, the low yield of the Ge-68/Ga-68 from which Gallium-68 is obtained and fewer installed PET/CT systems compared to the SPECT imaging systems may limit its availability. We, therefore, evaluated in a head-to-head comparison, the diagnostic sensitivity of Ga-6...

Journal: :Molecular and cellular biology 2006
Rebecca E Conway Nenad Petrovic Zhong Li Warren Heston Dianqing Wu Linda H Shapiro

The transmembrane peptidase prostate-specific membrane antigen (PSMA) is universally upregulated in the vasculature of solid tumors, but its functional role in tumor angiogenesis has not been investigated. Here we show that angiogenesis is severely impaired in PSMA-null animals and that this angiogenic defect occurs at the level of endothelial cell invasion through the extracellular matrix barr...

Journal: :Advanced healthcare materials 2013
Fayun Zhang Liang Shan Yuanyi Liu David Neville Jung-Hee Woo Yue Chen Alexandru Korotcov Stephen Lin Sophia Huang Rajagopalan Sridhar Wei Liang Paul C Wang

Prostate specific membrane antigen (PSMA) is overexpressed on prostate tumor cells and the neovascular endothelia various solid tumors. A bivalent immunotoxin generated by fusing a fold-back single-chain diabody derived from the Fv fragments of an anti-PSMA monoclonal antibody with a truncated diphtheria toxin (DT) containing the activity and translocation domains [A-dmDT390-scfbDb(PSMA)] might...

2015
B. Meller F. Bremmer C. O. Sahlmann S. Hijazi C. Bouter L. Trojan J. Meller P. Thelen

BACKGROUND Prostate-specific membrane antigen (PSMA) is a promising target for diagnostics and therapy of prostate carcinoma (PCa). Based on the hypothesis that PSMA expression can be modulated by variations in androgen deprivation therapy (ADT), we investigated the binding of a PSMA-directed radiopharmaceutical in vitro in order to get an insight of the interactions between altered premedicati...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2015
Martina Weineisen Margret Schottelius Jakub Simecek Richard P Baum Akin Yildiz Seval Beykan Harshad R Kulkarni Michael Lassmann Ingo Klette Matthias Eiber Markus Schwaiger Hans-Jürgen Wester

UNLABELLED On the basis of the high and consistent expression of prostate-specific membrane antigen (PSMA) in metastatic prostate cancer (PC), the goal of this study was the development, preclinical evaluation, and first proof-of-concept investigation of a PSMA inhibitor for imaging and therapy (PSMA I&T) for (68)Ga-based PET and (177)Lu-based endoradiotherapeutic treatment in patients with met...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017
Klaus Kopka Martina Benešová Cyril Bařinka Uwe Haberkorn John Babich

In recent years, several radioligands targeting prostate-specific membrane antigen (PSMA) have been clinically introduced as a new class of theranostic radiopharmaceuticals for the treatment of prostate cancer (PC). In the second decade of the 21st century, a new era in nuclear medicine was initiated by the clinical introduction of small-molecule PSMA inhibitor radioligands, 40 y after the clin...

Journal: :Molecular cancer therapeutics 2011
Xinning Wang Dangshe Ma William C Olson Warren D W Heston

Prostate-specific membrane antigen (PSMA) is a membrane protein that is overexpressed manifold in prostate cancer and provides an attractive target for therapy. PSMA ADC is an antibody-drug conjugate (ADC) that consists of a fully human anti-PSMA monoclonal antibody conjugated to monomethylauristatin E through a valine-citrulline linker. In this study, the antitumor activity of PSMA ADC was eva...

2017
José M. Oliveira Catarina Gomes Diogo B. Faria Tiago S. Vieira Fernando A. Silva Joana Vale Francisco L. Pimentel

The 68Ga-prostate-specific membrane antigen (68Ga-PSMA) has been recently developed to be used, as a ligand, in positron emission tomography/computed tomography (PET/CT) prostate cancer imaging, to detect prostate disease. The main objective of this review was to collect data and findings from other studies and articles to assess, theoretically, if 68GA-PSMA PET/CT is a more appropriate prostat...

2017
Aurelie Maisonial-Besset Tiffany Witkowski Isabelle Navarro-Teulon Odile Berthier-Vergnes Giovanna Fois Yingying Zhu Sophie Besse Olivia Bawa Arnaud Briat Mercedes Quintana Alexandre Pichard Mathilde Bonnet Eric Rubinstein Jean-Pierre Pouget Paule Opolon Lydia Maigne Elisabeth Miot-Noirault Jean-Michel Chezal Claude Boucheix Françoise Degoul

Tetraspanin 8 (TSPAN8) overexpression is correlated with poor prognosis in human colorectal cancer (CRC). A murine mAb Ts29.2 specific for human TSPAN8 provided significant efficiency for immunotherapy in CRC pre-clinical models. We therefore evaluate the feasability of targeting TSPAN8 in CRC with radiolabeled Ts29.2. Staining of tissue micro-arrays with Ts29.2 revealed that TSPAN8 espression ...

2017
Libo Zhang Douglass C Vines Deborah A Scollard Trevor McKee Teesha Komal Milan Ganguly Trevor Do Bing Wu Natasha Alexander Reza Vali Amer Shammas Travis Besanger Sylvain Baruchel

Peptide-receptor imaging and therapy with radiolabeled somatostatin analogs such as 68Ga-DOTA-TATE and 177Lu-DOTA-TATE have become an effective treatment option for SSTR-positive neuroendocrine tumors. The purpose of this study was to evaluate the correlation of somatostatin receptor-2 (SSTR2) expression with 68Ga-DOTA-TATE uptake and 177Lu-DOTA-TATE therapy in neuroblastoma (NB) xenograft mode...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید